Produktname:5,7-dichloro-8-fluoro-2-(methylsulfanyl)-3H,4H-pyrido[4,3-d]pyrimidin-4-one

IUPAC Name:5,7-dichloro-8-fluoro-2-(methylsulfanyl)-3H,4H-pyrido[4,3-d]pyrimidin-4-one

CAS:2763157-90-8
Molekulare Formel:C8H4Cl2FN3OS
Reinheit:95%+
Katalognummer:CM1043992
Molekulargewicht:280.1

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM1043992-100mg in stock ǺƩş
CM1043992-250mg in stock ǺȤŸ
CM1043992-1g in stock şǠȋ
CM1043992-5g in stock ǺƩȋȋ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:2763157-90-8
Molekulare Formel:C8H4Cl2FN3OS
Schmelzpunkt:-
SMILES-Code:CSC1=NC2=C(C(=O)N1)C(=NC(=C2F)Cl)Cl
Dichte:
Katalognummer:CM1043992
Molekulargewicht:280.1
Siedepunkt:
Mdl-Nr.:
Lagerung:

Category Infos

Column Infos

HRS-4642
HRS-4642 is a high affinity, selective, long-acting, and non-covalent KRAS G12D inhibitor, with an affinity constant of 0.083 nM. HRS-4642 demonstrated robust efficacy against KRAS G12D-mutant cancers both in vitro and in vivo. Importantly, in a phase 1 clinical trial, HRS-4642 exhibited promising anti-tumor activity in the escalating dosing cohorts. Furthermore, the sensitization and resistance spectrum for HRS-4642 was deciphered through genome-wide CRISPR-Cas9 screening, which unveiled proteasome as a sensitization target. HRS-4642, either as a single agent or in combination with carfilzomib, reshaped the tumor microenvironment toward an immune-permissive one.

Related Products